We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Funko (FNKO - Free Report) is a Zacks Rank #2 (Buy) and the stock has been nothing short of a runaway winner over the last few months. In this Bull of the Day article, we will take a look at the recent move in earnings estimates, the earnings history, and the valuation.
Description
Funko is a pop culture consumer products company, designs, sources, and distributes licensed pop culture products in the United States, China, Vietnam, and the United Kingdom. The company offers vinyl, bobble head, blind-packed miniature, and action figures; and plush products, accessories, apparels, and homewares, as well as bags, purses, and wallets. Funko, Inc. was founded in 2017 and is headquartered in Everett, Washington.
Earnings Estimates
The foundation of the Zacks Rank is the movement in earnings estimates. When estimates are moving up, the stock gets a better Zacks Rank. We have just that happening with FNKO.
Estimates have been moving up... but other stocks have seen even greater estimates. Those stocks are Zacks Rank #1 (Strong Buy) stocks, but with a Zacks Rank #2 (Buy) FNKO is also looking good.
THe 2018 Zacks Consensus Estimate has moved up a penny from where it was 90 days ago. The number for 2019 is up 3 cents over the same time horizon.
Earnings History
I see only two earnings reports Zacks has data for. There have been a total of three reports and importantly the year over year revenue rate has been higher for each report. That fact alone tells me that the company is growing.
In the two quarters that Zacks had estimates for, I see two monster beats. That should give investors confidence that the next report that could come in early August could be another beat.
At present, the Zacks Consensus Estimate stands at $123M in revenue and EPS of $0.02 for the Fiscal second quarter of 2018.
Valuation
FNKO sports an A for Growth and an A for Value and that isn't something that I always like to see. I am all about growth, so I like to see a strong growth style score and a weak value score because value investors and growth investors are inherently looking for different things. That said, a 21x forward earnings multiple is really low for a company that is seeing revenue growth north of 35% on an annual basis. The price to book of 2.4x is also well below the industry average. Zacks doesn't have a price to sales multiple, but I calculated a 0.6x number and that is seriously low for a company showing the growth in sales and margins that FNKO is seeing.
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Bull Of The Day: Funko (FNKO)
Funko (FNKO - Free Report) is a Zacks Rank #2 (Buy) and the stock has been nothing short of a runaway winner over the last few months. In this Bull of the Day article, we will take a look at the recent move in earnings estimates, the earnings history, and the valuation.
Description
Funko is a pop culture consumer products company, designs, sources, and distributes licensed pop culture products in the United States, China, Vietnam, and the United Kingdom. The company offers vinyl, bobble head, blind-packed miniature, and action figures; and plush products, accessories, apparels, and homewares, as well as bags, purses, and wallets. Funko, Inc. was founded in 2017 and is headquartered in Everett, Washington.
Earnings Estimates
The foundation of the Zacks Rank is the movement in earnings estimates. When estimates are moving up, the stock gets a better Zacks Rank. We have just that happening with FNKO.
Estimates have been moving up... but other stocks have seen even greater estimates. Those stocks are Zacks Rank #1 (Strong Buy) stocks, but with a Zacks Rank #2 (Buy) FNKO is also looking good.
THe 2018 Zacks Consensus Estimate has moved up a penny from where it was 90 days ago. The number for 2019 is up 3 cents over the same time horizon.
Earnings History
I see only two earnings reports Zacks has data for. There have been a total of three reports and importantly the year over year revenue rate has been higher for each report. That fact alone tells me that the company is growing.
In the two quarters that Zacks had estimates for, I see two monster beats. That should give investors confidence that the next report that could come in early August could be another beat.
At present, the Zacks Consensus Estimate stands at $123M in revenue and EPS of $0.02 for the Fiscal second quarter of 2018.
Valuation
FNKO sports an A for Growth and an A for Value and that isn't something that I always like to see. I am all about growth, so I like to see a strong growth style score and a weak value score because value investors and growth investors are inherently looking for different things. That said, a 21x forward earnings multiple is really low for a company that is seeing revenue growth north of 35% on an annual basis. The price to book of 2.4x is also well below the industry average. Zacks doesn't have a price to sales multiple, but I calculated a 0.6x number and that is seriously low for a company showing the growth in sales and margins that FNKO is seeing.
Chart
Funko, Inc. Price and Consensus
Funko, Inc. Price and Consensus | Funko, Inc. Quote
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>